Corporate News     25-Apr-24
Nestle India and Dr Reddy's to form JV focused on nutritional health solutions

Nestlé India and Dr. Reddy's Laboratories announced that they have entered into a definitive agreement to form a joint venture to bring innovative nutraceutical brands to consumers in India and other agreed territories.

The partnership will bring together the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestlé Health Science (NHSc) with the strong and established commercial strengths of Dr. Reddy's in India.

The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios in categories such as metabolic, hospital nutrition, general wellness , women's health and child nutrition for consumers across India. The JV Company will be headquartered in Hyderabad. The JV Company will leverage the capabilities as well as services of the Nestlé Group and Dr. Reddy's.

Select brands will be licensed by the JV Partners to the JV company. The Nestlé Group will license brands such as Nature's Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy's will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV Company is expected to become operational in Q2 of FY'25.

Previous News
  Dr Reddys Laboratories
 ( Results - Analysis 08-May-24   09:36 )
  Dr Reddy's Q4 PAT jumps 36% YoY to Rs 1,307 crore
 ( Hot Pursuit - 07-May-24   17:26 )
  Dr Reddy's Laboratories consolidated net profit rises 36.42% in the March 2024 quarter
 ( Results - Announcements 07-May-24   16:59 )
  Dr Reddys Laboratories AGM scheduled
 ( Corporate News - 07-May-24   16:41 )
  Board of Dr Reddys Laboratories recommends final dividend
 ( Corporate News - 07-May-24   16:41 )
  Dr Reddy's Labs launches generic Oracea capsules in US markets
 ( Hot Pursuit - 06-May-24   09:29 )
  Nifty fails to hold 22,500 level, Sensex tumbles 732 pts; Coal India up 4.75%
 ( Market Commentary - End-Session 03-May-24   16:54 )
  Dr Reddy's launches Doxycycline Capsules in the US
 ( Corporate News - 03-May-24   15:50 )
  Nestle India
 ( Results - Analysis 25-Apr-24   20:25 )
  Nestle India gains as PAT rises 27% YoY in Jan-March 2024 quarter
 ( Hot Pursuit - 25-Apr-24   13:26 )
  Board of Nestle India approves launch of Nespresso in India
 ( Corporate News - 25-Apr-24   13:11 )
Other Stories
  Veejay Lakshmi Engineering Works to convene board meeting
  09-May-24   11:53
  TVS Motor Company schedules AGM
  09-May-24   11:52
  PNGS Gargi Fashion Jewellery schedules AGM
  09-May-24   11:52
  Vivo Collaboration Solutions to announce Quarterly Result
  09-May-24   11:50
  Kothari Sugars & Chemicals announces board meeting date
  09-May-24   11:50
  Blue Pebble to table results
  09-May-24   11:50
  Globesecure Techs. to conduct board meeting
  09-May-24   11:50
  Mega Flex Plastics to table results
  09-May-24   11:49
  Vardhman Concrete to hold AGM
  09-May-24   11:49
  Shiv Aum Steel declare Quarterly Result
  09-May-24   11:49
Back Top